Hologic Inc at Citi Healthcare Conference (Virtual) Transcript
Well, great. Thank you for joining us at the Citi Healthcare Conference here. I'm Patrick Donnelly, the tools and diagnostics analyst with Citi. Excited to have Karleen Oberton with us from Hologic. She's the CFO. And Karleen, I know -- maybe we can give some introductory remarks, and then we can dive right into Q&A. And if investors have any questions, feel free to e-mail them over to me, and I will try to get them asked.
And Karleen, I'll turn it over to you.
Great. Thanks, Patrick, and it's a pleasure to be here today. So for those who may be not so familiar with the Hologic story, we are a medical technology company uniquely focused in women's health care. We have clinically differentiated market-leading products in each of our divisions. We are organized within 3 divisions: our Diagnostics, Breast Health and Surgical. And over 85% of our revenue today is recurring in nature between disposable revenues and service revenues. And
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |